21090 ⎘
Medicinal preparations containing antigens or antibodies; Bacterial antigens Mycobacterium, e.g. Mycobacterium tuberculosis
LIPOSOME HAVING LIPID MEMBRANE CONTAINING BACTERIAL CELL COMPONENT
#602fusion protein and uses thereof
#603METHOD FOR THE DIAGNOSIS OF TUBERCULOSIS
#604Methods and compositions for treating autoimmune diseases
#605Tuberculosis vaccine
#606Immunogenic compositions comprising polypeptides and fusions thereof
#607Compositions and methods for immunodominant antigens
#608TUBERCULOSIS NUCLEIC ACIDS, POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS
#609Tuberculosis vaccine and method of using same
#610Hypoxia inducible factor inducer and methods for using the same
#611Recombinant intracellular pathogen immunogenic compositions and methods of use
#612Prophylactic tuberculosis vaccine
#613Recombinant BCG strains with enhanced ability to escape the endosome
#614Therapeutic vaccine comprising mycobacterial heat shock protein 70
#615Compositions for eliciting an immune response against subspecies
#616Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#617VACCINES COMPRISING TB 10.4
#618Fusion proteins of mycobacterium tuberculosis
#619Flu vaccine admixture of mannan and flu antigen
#620Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#621Recombinant baculovirus vaccine
#622Methods for detecting a infection
#623Fusion proteins of
#624NOVEL PRIME-BOOST COMBINATIONS OF ATTENUATED MYCOBACTERIUM
#625Method of producing rough strains of bacteria and uses thereof
#626RECOMBINANT MYCOBACTERIUM STRAIN EXPRESSING A MYCOBACTERIAL FAP PROTEIN UNDER THE CONTROL OF A PROMOTER ACTIVE UNDER HYPOXIA AND ITS APPLICATION FOR CANCER THERAPY
#627Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene
#628Compositions and methods for immunodominant antigens of
#629Therapeutic agent for infections, and treatment method using the same
#630MEANS AND METHODS FOR MANIPULATING SEQUENTIAL PHAGOLYSOMALCYTOSOLIC TRANSLOCATION OF MYCOBACTERIA, AND USES THEREOF
#631Viral vaccine composition, process and methods of use
#632Immunogenic constructs
#633Immunogenic compositions for activating γδ T cells
#634Tuberculosis vaccines comprising antigens expressed during the latent infection phase
#635VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
#636Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
#637Mycobacterial Catalase-Peroxidase in the Diagnosis and Treatment of Sarcoidosis
#638Microbial vaccine and vaccine vector
#639Recombinant BCG tuberculosis vaccine designed to elicit immune responses to in all physiological stages of infection and disease
#640Preparation of antigen-presenting human γδ T cells and use in immunotherapy
#641Methods for producing an immune response to tuberculosis
#642Generation of new BCG vaccine strains protecting against the establishment of latent infection and reactivation from the latent or persistent state
#643Method for preventing or treating infection
#644Multivalent vaccines comprising recombinant viral vectors
#645Vaccines with enhanced immune response and methods for their preparation
#646Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#647Pharmaceutical compositions containing 1-methyl-D-tryptophan
#648Vaccines with enhanced immune response and methods for their preparation
#649Immunomodulator Compounds as Vaccine Enhancers
#650Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#651Recombinant BCG vaccine
#652Compounds and methods for diagnosis and immunotherapy of tuberculosis
#653Fusion proteins of mycobacterium tuberculosis
#654Fusion proteins of mycobacterium tuberculosis
#655Vaccine
#656Fusion proteins of mycobacterium tuberculosis
#657Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis Disease
#658Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#659Electroporation of and overexpression of antigens in mycobacteria
#660Disease Prevention and Vaccination Prior to Thymic Reactivation
#661Fusion proteins of
#662subspecies vaccines and methods of using the same
#663High Throughput Proteomics
#664MYCOBACTERIUM TUBERCULOSIS PERSISTANCE GENES
#665Vaccine compositions and adjuvant
#666Compositions for immunizing against mycobacterium
#667MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#668Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors
#669Mycoplasma subunit vaccine
#670Compounds and methods for diagnosis and immunotherapy of tuberculosis
#671Fusion proteins of Mycobacterium tuberculosis
#672Method for muscle delivery of drugs, nucleic acids and other compounds
#673Pili from
#674Pharmaceutical use of α antigen or α antigen gene
#675Vaccine composition containing synthetic adjuvant
#676Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
#677Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#678Recombinant BCG strains with enhanced ability to escape the endosome
#679Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
#680Therapeutic calcium phosphate particles and methods of manufacture and use
#681Vaccine Compositions Which Are Obtained From Streptomyces
#682Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#683Immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs
#684Lactoferrin: an adjuvant for vaccines
#685PARENTERAL LOW DOSE TYPE 1 INTERFERONS FOR BLADDER CANCER
#686Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#687Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#688Adjuvant Composition and Methods for Its Use
#689Use of mycrobacterial vaccines in CD4 or CD8 lymphocyte-deficient mammals
#690Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
#691COMPOSITIONS AND METHODS FOR DELIVERY OF PROTEINS AND ADJUVANTS ENCAPSULATED IN MICROSPHERES
#692Vaccine candidates against Johne's disease
#693Composition and method for the treatment of carcinoma
#694Recombinant intracellular pathogen immunogenic compositions and methods for use
#695Protein antigens useful for cancer therapy and vaccination
#696Vaccine delivery
#697Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein
#698Process for manufacturing pharmaceutical composition comprises of in the treatment of asthma (obstructive lung disease)
#699Compounds and methods for diagnosis and immunotherapy of tuberculosis
#700Antibody profiles characteristic of tuberculosis state
#701In vivo targeting of dendritic cells
#702Modified mycobacterium tuberculosis strains and uses thereof
#703Modified ESAT-6 molecules and improved vaccine strains of BCG
#704Mycoplasma subunit vaccine
#705Fusion proteins of antigens and their uses
#706Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
#707Adjuvant combinations of liposomes and mycobacteriaial lipids for immunization compositions and vaccines
#708HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof
#709Recombinant BCG vaccine
#710Fusion proteins of
#711Method of treating human-immunodeficiency virus (HIV) disease infection
#712Abundant extracellular products and methods for their production and use
#713Stress proteins and uses therefor
#714Stress proteins and uses therefor
#715Pharmaceutical use of alpha antigen or alpha antigen gene
#716Mycobacterium cell wall composition
#717Tuberculosis nucleic acids, polypeptides and immunogenic compositions
#718Regulated bacterial lysis for gene vaccine vector delivery and antigen release
#719Iontophoretic device and method for administering immune response-enhancing agents and compositions
#720Whole bacterial cells as immune modulator
#721Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria
#722Recombinant BCG strains with attenuated immunosuppressive properties
#723Method for muscle delivery of drugs, nucleic acids and other compounds
#724Fusion proteins of mycobacterium tuberculosis antigens and their uses
#725Mycobacterium smegmatis vaccine
#726Vaccine compositions and adjuvant
#727Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
#728Compositions comprising immune response altering agents and methods of use
#729Vaccine against microbial pathogens
#730Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and
#731Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#732Adjuvant combinations for immunization composition and vaccines
#733Probiotic propionibacterium
#734Method and composition
#735Stress proteins and uses therefor
#736Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein
#737Mycobacterial vaccine
#738Mycobacterium avium subspecies paratuberculosis oral vaccine and methods
#739Vaccine
#740Vaccine
#741Vaccines with enhanced immune response and methods for their preparation
#742Double auxotrophic mycobacterium and uses thereof
#743Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer